Amanote Research
Register
Sign In
Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled Opioid Receptor Antagonist Agent, DMT-Tic-Cy5
doi 10.1021/acs.molpharmaceut.5b00760.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Orally Administered H-DMT-Tic-Lys-Nh-Ch2-Ph (MZ-2), a Potent Μ-/Δ-Opioid Receptor Antagonist, Regulates Obese-Related Factors in Mice
European Journal of Pharmacology
Pharmacology
Cy5.5-Labeled Affibody Molecule for Near-Infrared Fluorescent Optical Imaging of Epidermal Growth Factor Receptor Positive Tumors
Journal of Biomedical Optics
Electronic
Optics
Molecular Physics,
Optical
Biomaterials
Atomic
Magnetic Materials
Biomedical Engineering
New Opioid Designed Multiple Ligand From DMT-Tic and Morphinan Pharmacophores
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Effect of Lysine at C-Terminus of the DMT-Tic Opioid Pharmacophore
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Quality Analysis of in Vivo Near-Infrared Fluorescence and Conventional Gamma Images Acquired Using a Dual-Labeled Tumor-Targeting Probe
Journal of Biomedical Optics
Electronic
Optics
Molecular Physics,
Optical
Biomaterials
Atomic
Magnetic Materials
Biomedical Engineering
Further Studies on Lead Compounds Containing the Opioid Pharmacophore DMT-Tic
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Effect of Lysine at C-Terminus of the DMT-Tic Opioid Pharmacophore
Improving Tumor-Targeting Capability and Pharmacokinetics Of99mTc-Labeled Cyclic RGD Dimers With PEG4Linkers
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
Dual-Modality Imaging of Prostate Cancer With a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
